MedPath

Study on Lipid Profile Changes in Plasma and Intestinal Mucosa of Patients With Inflammatory Bowel Disease

Not yet recruiting
Conditions
Inflammatory Bowel Diseases
Registration Number
NCT06680076
Lead Sponsor
First Affiliated Hospital of Harbin Medical University
Brief Summary

This study aimed to demonstrate the characteristic lipid profile changes in patients with inflammatory bowel disease.

Detailed Description

This study aimed to demonstrate the characteristic lipid profile changes in patients with inflammatory bowel disease.

The investigators followed up with patients with different stages of IBD and collected plasma and lesion tissues from patients and healthy volunteers for lipid metabolism-related substances to assess the changes in lipid metabolism in patients with different stages of IBD and their impact on disease.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Patients with inflammatory bowel disease; aged 18-80 years; all cases agreed to participate in the study.
  • Healthy volunteers who agreed to participate in the study.
Exclusion Criteria
  • Patients with severe heart disease; patients with severe kidney disease; patients with low blood pressure; patients with severe infections such as sepsis or pneumonia; patients who have used immunosuppressants such as 6-mercaptopurine, imidazole thiopurine, and cyclosporine within a short period, and women during pregnancy; patients who are post-colon resected; patients who disagreed to participate in the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differential lipid composition between disease and healthy groups14 weeks

Differences in lipid composition between disease and healthy groups.

Differences in lipid composition between active and remission disease14 weeks

Differences in lipid composition between active and remission disease

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Carol

🇨🇳

Harbin, Heilongjiang, China

© Copyright 2025. All Rights Reserved by MedPath